Cheesbrough A[au] - Search Results

Year	Number of Results
1995	1
2000	1
2005	1
2007	1
2014	2
2015	1
2019	1
2022	1
2023	0

1

Biobased Elastomer Nanofibers Guide Light-Controlled Human-iPSC-Derived Skeletal Myofibers.

Cheesbrough A, Sciscione F, Riccio F, Harley P, R'Bibo L, Ziakas G, Darbyshire A, Lieberam I, Song W. Cheesbrough A, et al. Adv Mater. 2022 May;34(18):e2110441. doi: 10.1002/adma.202110441. Epub 2022 Mar 31. Adv Mater. 2022. PMID: 35231133 Free PMC article.

2

Everyday wild: Urban natural areas, health, and well-being.

Cheesbrough AE, Garvin T, Nykiforuk CIJ. Cheesbrough AE, et al. Health Place. 2019 Mar;56:43-52. doi: 10.1016/j.healthplace.2019.01.005. Epub 2019 Jan 25. Health Place. 2019. PMID: 30690281

3

Estimated life expectancy of Parkinson's patients compared with the UK population.

Ishihara LS, Cheesbrough A, Brayne C, Schrag A. Ishihara LS, et al. Among authors: cheesbrough a. J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1304-9. doi: 10.1136/jnnp.2006.100107. Epub 2007 Mar 30. J Neurol Neurosurg Psychiatry. 2007. PMID: 17400591 Free PMC article.

4

Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects.

Allen A, Bal J, Cheesbrough A, Hamilton M, Kempsford R. Allen A, et al. Among authors: cheesbrough a. Br J Clin Pharmacol. 2014 May;77(5):808-20. doi: 10.1111/bcp.12263. Br J Clin Pharmacol. 2014. PMID: 24152086 Free PMC article. Clinical Trial.

5

The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol.

Kempsford R, Allen A, Bareille P, Hamilton M, Cheesbrough A. Kempsford R, et al. Among authors: cheesbrough a. Clin Pharmacol Drug Dev. 2015 Jan;4(1):2-11. doi: 10.1002/cpdd.160. Epub 2014 Dec 5. Clin Pharmacol Drug Dev. 2015. PMID: 27127998 Clinical Trial.

6

Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination.

Angus R, Reagon R, Cheesbrough A. Angus R, et al. Among authors: cheesbrough a. Int J Clin Pract. 2005 Feb;59(2):156-62. doi: 10.1111/j.1742-1241.2005.00455.x. Int J Clin Pract. 2005. PMID: 15854190

7

Statistical analysis of results.

Cheesbrough A. Cheesbrough A. J Hosp Infect. 1995 Sep;31(1):75-6. doi: 10.1016/0195-6701(95)90088-8. J Hosp Infect. 1995. PMID: 7499825 No abstract available.

8

Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-1-infected persons with previous nucleoside analogue and protease inhibitor use.

Moyle GJ, Wilkins E, Leen C, Cheesbrough A, Reynolds B, Gazzard BG. Moyle GJ, et al. Among authors: cheesbrough a. AIDS. 2000 Jul 7;14(10):1453-4. doi: 10.1097/00002030-200007070-00020. AIDS. 2000. PMID: 10930162 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results